Between 28 August and 3 September, South Africa recorded 1,262 new cases of COVID-19.
There have been 4,012,860 laboratory-confirmed COVID-19 cases in South Africa to far.
The newest data from the National Institute of Communicable Diseases (NICD) showed a 5% decrease in newly diagnosed cases compared to the previous week.
In the previous week, the NICD reported that Gauteng had the greatest incidence risk (3,4 cases per 100 000 people), followed by Western Cape (2,5 cases per 100 000 people), while the remainder of the provinces recorded incidence rates below 2,5 cases per 100 000 people.
In the previous week, six of the nine provinces reported a drop in the chance of weekly occurrence.
The decline varied from 0.1 cases per 100 000 people in Limpopo (9.4% drop) to 0.5 cases per 100 000 people in KwaZulu-Natal (20.9% decrease).
Meanwhile, Mpumalanga, North West, and Western Cape reported a rise in the weekly incidence, with 0.70 cases per 100 000 people (a 55.2% increase), 0.60 cases per 100 000 people (a 46.3% increase), and 0.10 cases per 100 000 people (a 2.3% increase), respectively.
In addition, the national public health institute reported a 40% decline in new hospital admissions, with 104 patients hospitalised as opposed to 173 the previous week.
“Delays in reporting of admissions and deaths may affect the numbers reported in the most recent week.”
In the previous week, 37 patients were admitted to hospitals in Gauteng, followed by 29 in KwaZulu-Natal, 11 in the Western Cape, and nil in both Limpopo and Northern Cape.
In week 35 of 2022, the largest weekly incidence risk of COVID-19 admissions was among those aged 65 and older, whereas the lowest weekly incidence risk was among those less than age 20 and those aged 20 to 34 years.
South Africa provided 8 182 vaccine doses in the previous 24 hours, bringing the total to 37 506 007, according to the Department of Health.
This indicates that there are currently 20 366 036 vaccinated adults in the nation, of whom 18 575 025 are completely immunised.
Meanwhile, the department’s data indicate that 2,676,290 doses of vaccination were administered to children aged 12 to 17.